Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Anushka Mukherjee

Is Pfizer Stock Underperforming the Dow?

Founded 170 years ago and currently headquartered in New York, Pfizer Inc. (PFE) is a global biopharmaceutical powerhouse with a presence in over 125 countries. At its core, Pfizer researches, develops, manufactures and markets medicines and vaccines across a wide spectrum: from oncology to immunology, internal medicine, rare diseases, and preventive vaccines. 

With a market capitalization of roughly $146 billion, Pfizer slots squarely into the “large-cap” league, a category typically defined as companies worth about $10 billion or more.  And while the post-pandemic drop in COVID-19 product demand has challenged the company, the pharmaceutical giant is powering ahead with a refreshed lineup of innovative medicines and vaccines. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.